Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment

Biochemical Pharmacology
Mi-Kyung KimYong-Sang Song

Abstract

Human papillomavirus (HPV) infection is considered to be the necessary cause of cervical cancer. E6 and E7 oncoproteins of HPV have been known to play major roles in malignant transformation of cervical cells, inhibiting the tumor suppressors p53 and Rb. However, the role of E5 oncoprotein has been relatively less defined. HPV 16 E5 is a hydrophobic membrane-bound protein which associates with the Golgi apparatus, endoplasmic reticulum and perinuclear membrane. Accumulating evidences have suggested that E5 oncoprotein may also contribute to cervical carcinogenesis through modulating cellular signaling pathways in addition to augmenting the immortalization potential of E6 and E7. Multiple mechanisms, including activation of EGFR or inflammatory cell signaling pathway, have been implicated in malignant transformation by HPV 16 E5. Therefore, targeting E5 may be a rational approach for chemoprevention and treatment of cervical cancer, and understanding its oncogenic processes may help us to design novel therapeutic strategies. In this review, we discussed the roles of HPV 16 E5 in cervical carcinogenesis, altering several cellular signaling pathways involved in cell proliferation, angiogenesis and apoptosis.

References

Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Gross-MesilatyA Ciechanover
Jan 9, 1999·Oncogene·M Thomas, L Banks
Oct 6, 1999·The Annals of Thoracic Surgery·Y OhtaY Watanabe
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Oct 24, 2000·Obstetrics and Gynecology·W F ChengC Y Hsieh
Apr 5, 2001·International Journal of Radiation Oncology, Biology, Physics·D K GaffneyM Dodson
Apr 5, 2001·Journal of Biomedical Science·J L ChangS L Chen
Dec 26, 2001·Oncogene·D DiMaio, D Mattoon
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FerrandinaF O Ranelletti
Jun 5, 2002·Nature Reviews. Cancer·Harald zur Hausen
Apr 10, 2004·The Journal of Biological Chemistry·Maria FilippovaPenelope J Duerksen-Hughes
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H MooreThomas F Rocereto
Jan 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J DannenbergRaymond N DuBois
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Sep 29, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Lukas A HeflerAlexander Reinthaller
Mar 17, 2006·Cancer Research·Xinrong MaAmy M Fulton
Apr 4, 2007·International Journal of Cancer. Journal International Du Cancer·Jennifer S SmithGary M Clifford
May 15, 2007·The New England Journal of Medicine·UNKNOWN FUTURE II Study Group

❮ Previous
Next ❯

Citations

Oct 22, 2013·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Shu-Jie LiaoDing Ma
Jan 21, 2012·Cellular Oncology (Dordrecht)·Niladri Ganguly
Nov 15, 2011·Molecular Cancer·Aldo VenutiGiuseppe Borzacchiello
Nov 17, 2015·Expert Review of Anticancer Therapy·Gulden MenderesAlessandro D Santin
Jun 25, 2013·Expert Opinion on Investigational Drugs·Su-Juan WangLu-Ping Qin
Aug 14, 2012·Critical Reviews in Oncology/hematology·Ivan Diaz-PadillaAna Oaknin
Feb 18, 2016·BioMed Research International·Bhornprom YoysungnoenSuthiluk Patumraj
Jul 28, 2015·Biologicals : Journal of the International Association of Biological Standardization·Anoop KumarMausumi Bharadwaj
Jun 4, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Bao Hua LiXing Xie
May 21, 2015·Infectious Agents and Cancer·Luc Magloire Anicet BoumbaMustapha Moulay Ennaji
Jan 7, 2014·Biochimica Et Biophysica Acta·Antonio Carlos de FreitasMaria da Conceição Gomes Leitão
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Marcelo Nazário CordeiroAldo Venuti
Nov 22, 2017·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·V H de AlmeidaC Sternberg
May 10, 2020·Molecular Biology Reports·Nima HemmatHossein Bannazadeh Baghi
Nov 21, 2018·Infectious Agents and Cancer·Nima Hemmat, Hossein Bannazadeh Baghi
Nov 16, 2019·BMC Complementary and Alternative Medicine·Eun Suk SonJeong-Woong Park
Jan 29, 2021·Vaccines·Yue ZhaoAlexandr V Bazhin
May 10, 2021·Journal of Gynecology Obstetrics and Human Reproduction·Mohammad AbbasFarzana Mahdi
Sep 11, 2019·Pathogens and Disease·Nima Hemmat, Hossein Bannazadeh Baghi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis